Navigation Links
Old flu drugs not effective against seasonal influenza

Researcher Tom Jefferson and colleagues from Cochrane Collaboration (International private organization which reports review from compiling data from various clinical trials) reviewed data from over 50 clinical trials involving influenza symptoms and treatment. //

The researchers found that the old drugs which were used against influenza were not found to be effective now, some drugs like amantadine and rimantidine which were used to control symptoms and kill influenza was not found to be effective against present flu virus strains and they don’t have any effect against them but only lead to side effects of the drug.

The researchers also said that the new antiflu drugs which were said to be useful against influenza symptoms apart from bird flu infection was also not very useful in treating the influenza disease. The new drugs Tamiflu and Relenza would only be helpful in treating severe pandemic diseases of bird flu in humans and would not have any effective against the seasonal influenza virus infection.

The pharmaceutical manufacturers of Relenza and Tamiflu were not happy with the review results and has said that the results are not very encouraging as they feel in their trial on humans they found both these drugs Relenza and Tamiflu were very effective in controlling seasonal influenza infection besides bird flu infection.

Cochrane Review has done this review from collecting data from research done for the past 40 years in the field of influenza diseases and their symptoms and the review committee has published their review in the Lancet.


'"/>




Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
3. African HIV strains more resistant to anti HIV drugs
4. Right drugs drastically cut stroke risk
5. Relating heart protection and antihypertensive drugs
6. Enzyme may be target for obesity drugs
7. New HIV cases resist drugs
8. Relief to pregnant women using fertility drugs
9. AIDS drugs linked to heart attack risk
10. FDA debates status of decongestant drugs
11. Status of some prescription drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of ... college Bible teacher residing in North Carolina with his wife, Anna Marie. He and ... with six grandchildren. David is also the author of “Shadow and Substance.” , “Love, ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the National Council ... programs. The NCTQ report suggests, based on a review of GPA and SAT/ACT requirements ... quality in the U.S. It argues that this higher bar should be set by ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
(Date:3/23/2017)... (PRWEB) , ... March 23, ... ... and financial services firm serving the families and businesses of the Norwalk ... enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar. 24, 2017 Research ... Management in the U.S.: Consumer Strategies" report to their ... ... how adults approach and treat their physical pain, emphasizing consumer ... distinct groups: pain sufferers and adults who have selected illnesses/conditions ...
(Date:3/24/2017)... SHANGHAI , March 24, 2017 /PRNewswire/ ... organization providing high-quality and cost-effective drug development ... the pharmaceutical and biotechnology industry, announced today ... ShangPharma will be consolidating the ... Organizations (CMO) under Shanghai ChemPartner. These entities ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
Breaking Medicine Technology: